EP 2233131 A1 20100929 - Pharmaceutical composition containing levodopa, entacapone and carbidopa
Title (en)
Pharmaceutical composition containing levodopa, entacapone and carbidopa
Title (de)
Pharmazeutische Verbindung mit Levodopa, Entacapon und Carbidopa
Title (fr)
Composition pharmaceutique contenant de la lévodopa, un inhibiteur de la catéchol-O-méthyl-transférase et de la carbidopa
Publication
Application
Priority
EP 09155908 A 20090323
Abstract (en)
The present invention relates to a pharmaceutical composition of entacapone, levodopa and carbidopa or phamiaceutically aceptable salts or hydrates thereof characterized in that it comprises a first mixture of entacapone and levodopa and a second mixture of levodopa and carbidopa. The invention also relates to a preparation method of said composition.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/00 (2006.01)
CPC (source: EP)
A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01)
Citation (applicant)
- US 5446194 A 19950829 - BAECKSTROEM REIJO J [FI], et al
- EP 1189608 B1 20030723 - ORION CORP [FI]
- WO 2008053297 A2 20080508 - WOCKHARDT RESEARCH CENTER [IN], et al
- DRUG DEVELOPMENT RESEARCH, vol. 49, no. 4, 2000, pages 238 - 244
Citation (search report)
- [XI] US 2008118556 A1 20080522 - DEVANE JOHN G [IE], et al
- [Y] US 2003017201 A1 20030123 - VIRKKI MATTI [FI], et al
- [Y] WO 2007069274 A2 20070621 - TORRENT PHARMACEUTICALS LTD [IN]
- [Y] US 2006222703 A1 20061005 - POLITI GIOVANNI [FI]
- [A] WO 9212710 A1 19920806 - ISIS CHEMIE GMBH [DE]
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
EP 2233131 A1 20100929; EP 2410994 A1 20120201; WO 2010108845 A1 20100930
DOCDB simple family (application)
EP 09155908 A 20090323; EP 10709220 A 20100318; EP 2010053532 W 20100318